Cue Biopharma (NASDAQ:CUE) Posts Quarterly Earnings Results
Cue Biopharma (NASDAQ:CUE – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.20) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.09, Zacks reports. The business had revenue of $2.66 million for the quarter, compared to analysts’ expectations of $1.12 million. Cue Biopharma had a negative return on […]
More Stories
Forbes’ Top 20 Highest-Paid Female Athletes
Nowadays, people’s interest in sports is increasing continuously, and simultaneously net worth and earnings of the players are also increasing....
Rubio: US Won’t Tolerate Adversaries Controlling Venezuela, Its Oil Reserves
By Emel Akan WASHINGTON—Secretary of State Marco Rubio, speaking Sunday on NBC’s “Meet the Press,” said that the United States...
Trump Praised for Bold, Unprecedented Venezuela Operation
By Emel Akan WASHINGTON—On Saturday morning, Jan. 3, many Americans woke up to news that U.S. special forces had captured...
Much of Maduro’s Security Team Killed in US Action, Venezuela Defense Minister Says
By Jack Phillips A significant portion of Venezuelan socialist leader Nicolás Maduro’s security team was killed in the U.S. operation...
Starlink Provides Free Services for Venezuelans Until Feb. 3
By Jacki Thrapp Elon Musk’s Starlink will offer free services in Venezuela for nearly a month, the company announced in...
New Year’s Gas Prices 23 Cents Cheaper Than a Year Ago in US
By Tom Ozimek American drivers began the new year with further relief at the gas pump, as national average gasoline...